MedPath

Post-diagnostic support program for people with dementia and carers

Not Applicable
Recruiting
Conditions
dementia
Neurological - Dementias
Registration Number
ACTRN12622001522707
Lead Sponsor
niversity of Canberra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Eligible participants will be people with dementia (all forms) and their carer (as nominated by the person with dementia). Participants will be living independently in the community and will be recruited from within the ACT. People with dementia will be required to participate with a carer. The carer may be male or female, must be aged over 18 years, and providing ongoing support to the person with dementia. Potential participants will be screened using the Clinical Dementia Rating scale (CDR). Participants with mild to moderate scores of between 0.5 and 2 will be eligible to participate. Participants need to be willing to attend for greater than 10 weeks (i,e. do not have a holiday planned).

Exclusion Criteria

People with dementia may be excluded if they are unable to engage in, or requires 1:1 support for group participation due to disruptive behaviours and/or wandering behaviour, or severely impaired hearing or vision. Participants with a CDR score of 0 and 3 will be excluded. People with dementia who do not have a carer or support person willing to participate in required program components will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. The primary outcome will be change in the DEMQOL (Dementia Health-related Quality of Life). The 28-item questionnaire is designed for people with dementia (DEMQOL) (Smith, Lamping et al. 2005). The DEMQOL is a self-reported, interviewer-assessed questionnaire that inquires about the person with dementia’s feelings, memory, and everyday life activities from the last week. [Intervention group: <br>T1 = Baseline/Pre-intervention<br>T2 = Post-intervention at week 12 <br>T3 = Follow-up at week 24 (Primary endpoint)<br><br>Waiting-list group:<br>T0 = Baseline<br>T1 = Pre-intervention at week 12 <br>T2 = Post-intervention at week 24<br>T3 = Follow-up at week 36 (Primary endpoint)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath